Thompson Street Capital Partners Makes Growth Investment in Sabai Global

February 6, 2023

Thompson Street Capital Partners (TSCP) completed a growth investment in Sabai Global, a Chesterfield, Missouri-based provider of biosafety consulting, regulatory review, and central IRB services for clinical research. The investment will support Sabai’s continued expansion of services—particularly in cell and gene therapy—across pharmaceutical sponsors, CROs, academic health systems, and clinical research site networks.

Buyers
Thompson Street Capital Partners
Targets
Sabai Global
Location
Missouri, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.